| KŘIVANOVÁ, Andrea, Roman HÁJEK, Marta KREJČÍ, Vlastimil ŠČUDLA, Karel INDRÁK, J. BAČOVSKÝ, Tomáš BÜCHLER, A. SVOBODNÍK, Zdeněk ADAM, Jiří MAYER and Jiří VORLÍČEK. Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group. Onkologie. Switzerland: Karger, 2004, vol. 27, No 3, p. 275-279. ISSN 0378-584X. |
Other formats:
BibTeX
LaTeX
RIS
@article{837994,
author = {Křivanová, Andrea and Hájek, Roman and Krejčí, Marta and Ščudla, Vlastimil and Indrák, Karel and Bačovský, J. and Büchler, Tomáš and Svobodník, A. and Adam, Zdeněk and Mayer, Jiří and Vorlíček, Jiří},
article_location = {Switzerland},
article_number = {3},
keywords = {multiple myeloma; autologous transplantation},
language = {eng},
issn = {0378-584X},
journal = {Onkologie},
title = {Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group},
volume = {27},
year = {2004}
}
TY - JOUR
ID - 837994
AU - Křivanová, Andrea - Hájek, Roman - Krejčí, Marta - Ščudla, Vlastimil - Indrák, Karel - Bačovský, J. - Büchler, Tomáš - Svobodník, A. - Adam, Zdeněk - Mayer, Jiří - Vorlíček, Jiří
PY - 2004
TI - Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group
JF - Onkologie
VL - 27
IS - 3
SP - 275-279
EP - 275-279
PB - Karger
SN - 0378584X
KW - multiple myeloma
KW - autologous transplantation
N2 - High-dose chemotherapy followed by autologous stem cell transplantation (AT) is accepted as first-line therapy for patients with multiple myeloma (MM), with very good tolerance and low mortality (2-3%). We tested repeated transplantation with different experimental maintenance therapies in patients with MM relapsing/progressing after first AT. Results were compared using intra-individual analyses, therefore inter-individual differences are excluded (T2 model). Repeated AT is a feasible and successful strategy in treatment of relapsing MM; response to second AT and toxicity were acceptable and similar to the first AT in our assessment.
ER -
KŘIVANOVÁ, Andrea, Roman HÁJEK, Marta KREJČÍ, Vlastimil ŠČUDLA, Karel INDRÁK, J. BAČOVSKÝ, Tomáš BÜCHLER, A. SVOBODNÍK, Zdeněk ADAM, Jiří MAYER and Jiří VORLÍČEK. Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group. \textit{Onkologie}. Switzerland: Karger, 2004, vol.~27, No~3, p.~275-279. ISSN~0378-584X.
|
